Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aligos Therapeutics, Inc.

11.44
+1.1611.28%
Post-market: 11.450.0100+0.09%18:54 EDT
Volume:137.74K
Turnover:1.56M
Market Cap:69.95M
PE:-0.89
High:11.76
Open:10.75
Low:10.62
Close:10.28
Loading ...

Aligos Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
23 Oct 2024

Press Release: Ipsen delivers strong sales momentum in the first nine months of 2024 and increases its full-year guidance

Dow Jones
·
23 Oct 2024

BRIEF-Aligos Therapeutics Announces U.S. FDA Clearance Of Ind Application For Alg-000184

Reuters
·
22 Oct 2024

Aligos Therapeutics Inc - Phase 2 Filing for Alg-000184 Planned for Q1 2025

THOMSON REUTERS
·
22 Oct 2024

Aligos Therapeutics Announces U.S. FDA Clearance of Ind Application for Alg-000184

THOMSON REUTERS
·
22 Oct 2024

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184

GlobeNewswire
·
22 Oct 2024

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data From Alg-000184 in Chb Subjects and Late-Breaker Oral Presentation of Data From the Phase 2a Herald Study of Alg-055009 in Mash Subjects at the Liver Meeting (Tlm) 2024

THOMSON REUTERS
·
15 Oct 2024

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024

GlobeNewswire
·
15 Oct 2024

Aligos Therapeutics announces inducement grants under Nasdaq listing rule

TIPRANKS
·
11 Oct 2024

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
11 Oct 2024

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
11 Oct 2024

Aligos Therapeutics appoints David Perry as VP, business development

TIPRANKS
·
01 Oct 2024

Aligos Therapeutics Appoints David Perry as Vice President of Business Development

THOMSON REUTERS
·
01 Oct 2024

Aligos Therapeutics Appoints David Perry as Vice President of Business Development

GlobeNewswire
·
01 Oct 2024

Aligos Therapeutics to Present at Investor Conferences in October

GlobeNewswire
·
30 Sep 2024

Sony Electronics Changes the Game with the INZONE M10S and M9 II - with a New OLED Gaming Monitor Developed with Fnatic

PR Newswire
·
25 Sep 2024